SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-22-007614
Filing Date
2022-11-14
Accepted
2022-11-14 08:50:45
Documents
57
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aclarion_i10q-093022.htm   iXBRL 10-Q 761003
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER aclarion_ex3101.htm EX-31.1 8087
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER aclarion_ex3102.htm EX-31.2 8215
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, aclarion_ex3201.htm EX-32.1 3999
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, aclarion_ex3202.htm EX-32.2 4026
  Complete submission text file 0001683168-22-007614.txt   3845411

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE acon-20220930.xsd EX-101.SCH 35063
7 XBRL CALCULATION FILE acon-20220930_cal.xml EX-101.CAL 41853
8 XBRL DEFINITION FILE acon-20220930_def.xml EX-101.DEF 171791
9 XBRL LABEL FILE acon-20220930_lab.xml EX-101.LAB 245634
10 XBRL PRESENTATION FILE acon-20220930_pre.xml EX-101.PRE 225693
51 EXTRACTED XBRL INSTANCE DOCUMENT aclarion_i10q-093022_htm.xml XML 450754
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

IRS No.: 473324725 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41358 | Film No.: 221380756
SIC: 8071 Services-Medical Laboratories